More Children Are Surviving Long Enough for Heart Transplants—But Not Enough Hearts Exist, Say Experts

More babies and children are surviving long enough to receive a heart transplant than in previous decades, but the number of available donor hearts remains critically insufficient, according to recent research and clinical observations. Experts emphasize that while medical advances have improved survival rates for children awaiting transplantation, the persistent shortage of pediatric donor organs continues to limit access to life-saving treatment.

Improvements in pediatric heart failure management, including better use of mechanical circulatory support devices and optimized medical therapy, have allowed more children to stabilize while waiting for a transplant. A study led by Stanford Medicine experts, published in the Journal of the American College of Cardiology and updated in March 2026, found that increased survival on the waitlist is due to enhanced medical care, not changes in waitlist prioritization rules. The study noted that the current U.S. System for ranking children awaiting heart transplants does not consistently prioritize the sickest patients, which may contribute to avoidable risks.

Despite these advances in pre-transplant care, the fundamental barrier remains the scarcity of suitable donor hearts for children. Size and immunological compatibility requirements craft pediatric donor organs particularly rare compared to adult organs. International data show that the majority of pediatric heart transplants occur in North America and Europe, with significant disparities in access based on geographic and economic factors.

A survey of twenty-eight European countries published in April 2026 revealed that while most nations follow established organ allocation protocols such as Eurotransplant or Scandiatransplant, variations in listing practices and resource availability affect equity in access. In resource-limited settings, infrastructure constraints, lack of specialized transplant centers, and insufficient organ donation rates further exacerbate the gap between necessitate and availability.

Experts agree that addressing the donor shortage requires multifaceted strategies, including increasing public awareness about pediatric organ donation, supporting donation after circulatory death (DCD) pathways, and investing in technologies that may expand the donor pool. Until such measures significantly increase the number of available pediatric hearts, many children will continue to face prolonged waits or die before receiving a transplant.

The medical community continues to advocate for policy reforms and systemic improvements to both optimize the use of existing donor organs and expand the donor pool. As one specialist noted, “We are getting better at keeping children alive long enough for transplant—but we still aren’t getting enough hearts to them.”